Table 1. Basic characteristic of patients with breast cancer and the control individuals.
Characteristics | Cases (N = 530) | Controls (N = 628) | p-value |
---|---|---|---|
Age | 0.211 | ||
Mean ± SD | 50.69 ± 11.74 | 51.04 ± 9.64 | |
Menopause | 0.909 | ||
Premenopausal | 216 (40.8%) | 258 (41.1%) | |
Postmenopausal | 314 (59.2%) | 370 (58.9%) | |
Clinical Stages | |||
I | 232 (43.8%) | ||
II/III/IV | 298 (56.2%) | ||
Estrogen Receptor | |||
Negative | 220 (41.5%) | ||
Positive | 310 (58.5%) | ||
Progestrone Receptor | |||
Negative | 278 (52.5%) | ||
Positive | 252 (47.5%) | ||
HER2 | |||
Negative | 208 (39.2%) | ||
Positive | 322 (60.8%) |